First wave of Humira biosimilars enters EU market
Novartis and Amgen have announced today that their biosimilars to Humira are available across the European market.
Top Headlines
Global Industry News
-
Axim Biotech ‘closes GMP circle’ with manufacturing license for cannabinoids
from in-PharmaTechnologist.com
-
Dr. Reddy’s continues sell-off to Neopharma with Hyderabad API plant
from in-PharmaTechnologist.com
-
WuXi launches library with access to 80m DNA-Encoded small molecules
from Outsourcing-Pharma.com
-
Charles River secures five-year, $95.7m insourcing contract
from Outsourcing-Pharma.com
Hot Topics
-
CBMG inks Kymriah deal: ‘China could take the lead in cell therapies’
Emerging Markets
-
Merck biosimilar made available on the US VA National Formulary
Biosimilars
-
Be the Match partners to improve traceability of cell and gene therapies
Cell & Gene Therapies
-
Plant-based expression system produces higher yields than mammalian alternatives, says CEO
Biosimilars
